{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:12:11Z","timestamp":1777554731557,"version":"3.51.4"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01 CA243695"],"award-info":[{"award-number":["U01 CA243695"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and aims<\/jats:title>\n                    <jats:p>Germline genetic testing is recommended for all patients with ovarian or pancreatic cancer, and alternative service delivery models are needed to meet this demand. We evaluated an electronic decision aid (DA) that can be administered during a visit with an oncology provider. The DA centered around the decision to pursue genetic testing and selection of a specific multi-gene panel.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An electronic DA had previously been developed by a multi-disciplinary team. Patients were enrolled at two academic medical centers. We surveyed participants with ovarian or pancreatic cancer who completed the DA about their experience and knowledge gained. Oncology providers were also surveyed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ninety-two patients were enrolled. The DA took 13.7\u2009min to complete. There was a 20% increase in knowledge scores after using the DA. Ninety-five percent opted to pursue genetic testing; 20% chose the smallest cancer-specific gene panel, 31% chose the mid-size multi-cancer panel, and 49% chose the largest panel that included limited evidence genes. Nearly all participants (93%) indicated the DA helped their decision-making, and 95% would recommend the DA to friends interested in genetic testing. Ninety-one percent of providers felt patients were well-informed about genetic testing options and 93% indicated the DA did not extend appointment times.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Use of a DA for genetic testing is feasible and acceptable. Patients and providers expressed high levels of satisfaction. The wide range of multi-gene panels selected highlights the importance of offering choice. Studies to formally compare the performance of the DA with traditional genetic counseling are warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rescon\/vmag026","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:00:27Z","timestamp":1773932427000},"source":"Crossref","is-referenced-by-count":0,"title":["Feasibility and acceptability of an electronic decision aid for genetic testing in ovarian and pancreatic cancer patients"],"prefix":"10.1093","volume":"1","author":[{"given":"Danielle A","family":"Lynch","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Massachusetts General Hospital , Boston, MA 02114,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Wiser","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Massachusetts General Hospital , Boston, MA 02114,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devanshi","family":"Patel","sequence":"additional","affiliation":[{"name":"Center for Cancer Risk Assessment, Massachusetts General Hospital , Boston, MA 02114,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kajal","family":"Patel","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Massachusetts General Hospital , Boston, MA 02114,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ava","family":"Siegel","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Massachusetts General Hospital , Boston, MA 02114,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mackenzie","family":"Wooters","sequence":"additional","affiliation":[{"name":"Center for Cancer Risk Assessment, Massachusetts General Hospital , Boston, MA 02114,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Rodgers-Fouche","sequence":"additional","affiliation":[{"name":"Center for Cancer Risk Assessment, Massachusetts General Hospital , Boston, MA 02114,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Bouberhan","sequence":"additional","affiliation":[{"name":"Cancer Center, Massachusetts General Hospital , Boston, MA 02114,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Weekes","sequence":"additional","affiliation":[{"name":"Cancer Center, Massachusetts General Hospital , Boston, MA 02114,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana","family":"Addo-Tabiri","sequence":"additional","affiliation":[{"name":"Hematology and Medical Oncology, Boston University Chobanian and Avedisian School of Medicine , Boston, MA 02118,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Zayhowski","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences and Education, Boston University Chobanian and Avedisian School of Medicine , Boston, MA 02118,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Pottier","sequence":"additional","affiliation":[{"name":"Hematology and Medical Oncology, Boston University Chobanian and Avedisian School of Medicine , Boston, MA 02118,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen R","family":"Sepucha","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Health Decision Sciences Center, Massachusetts General Hospital , Boston, MA 02114,","place":["United States"]},{"name":"Division of General Internal Medicine, Massachusetts General Hospital , Boston, MA 02114,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchiao","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Massachusetts General Hospital , Boston, MA 02114,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen M","family":"Shannon","sequence":"additional","affiliation":[{"name":"Center for Cancer Risk Assessment, Massachusetts General Hospital , Boston, MA 02114,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8226-7005","authenticated-orcid":false,"given":"Daniel C","family":"Chung","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Massachusetts General Hospital , Boston, MA 02114,","place":["United States"]},{"name":"Center for Cancer Risk Assessment, Massachusetts General Hospital , Boston, MA 02114,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"2026042814062603300_vmag026-B1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Daly","year":"2021","journal-title":"J Natl Compr Canc Netw."},{"key":"2026042814062603300_vmag026-B2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.6004\/jnccn.2023.7333","article-title":"Hereditary cancer clinics improve adherence to NCCN germline testing guidelines for pancreatic cancer","volume":"22","author":"Rosso","year":"2024","journal-title":"J Natl Compr Cancer Netw"},{"key":"2026042814062603300_vmag026-B3","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.ygyno.2021.05.011","article-title":"Achieving universal genetic assessment for women with ovarian cancer: are we there yet? A systematic review and meta-analysis","volume":"162","author":"Lin","year":"2021","journal-title":"Gynecol Oncol."},{"key":"2026042814062603300_vmag026-B4","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1007\/s10897-013-9598-y","article-title":"Genetic risk assessment for women with epithelial ovarian cancer: referral patterns and outcomes in a university gynecologic oncology clinic","volume":"22","author":"Petzel","year":"2013","journal-title":"J Genet Couns."},{"key":"2026042814062603300_vmag026-B5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1080\/08998280.2019.1612702","article-title":"Barriers to the utilization of genetic testing and genetic counseling in patients with suspected hereditary breast and ovarian cancers","volume":"32","author":"Swink","year":"2019","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"2026042814062603300_vmag026-B6","doi-asserted-by":"publisher","first-page":"e23523","DOI":"10.2196\/23523","article-title":"Barriers and facilitators to genetic service delivery models: scoping review","volume":"10","author":"Raspa","year":"2021","journal-title":"Interact J Med Res."},{"key":"2026042814062603300_vmag026-B7","author":"Board PCGE","year":"2022"},{"key":"2026042814062603300_vmag026-B8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/gim.2014.85","article-title":"Multiplex genetic testing: reconsidering utility and informed consent in the era of next-generation sequencing","volume":"17","author":"Bradbury","year":"2015","journal-title":"Genet Med."},{"key":"2026042814062603300_vmag026-B9","doi-asserted-by":"publisher","first-page":"a002154","DOI":"10.1101\/mcs.a002154","article-title":"The impact of hereditary cancer gene panels on clinical care and lessons learned","volume":"3","author":"Okur","year":"2017","journal-title":"Cold Spring Harb Mol Case Stud."},{"key":"2026042814062603300_vmag026-B10","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1136\/ijgc-2020-001261","article-title":"BRCA testing in women with high-grade serous ovarian cancer: gynecologic oncologist-initiated testing compared with genetics referral","volume":"30","author":"Piedimonte","year":"2020","journal-title":"Int J Gynecol Cancer."},{"key":"2026042814062603300_vmag026-B11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13053-020-0136-2","article-title":"Group plus \u201cmini\u201d individual pre-test genetic counselling sessions for hereditary cancer shorten provider time and improve patient satisfaction","volume":"18","author":"Hynes","year":"2020","journal-title":"Hered Cancer Clin Pract"},{"key":"2026042814062603300_vmag026-B12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3390\/cancers10110435","article-title":"Next-generation service delivery: a scoping review of patient outcomes associated with alternative models of genetic counseling and genetic testing for hereditary cancer","volume":"10","author":"McCuaig","year":"2018","journal-title":"Cancers (Basel)"},{"key":"2026042814062603300_vmag026-B13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ygyno.2017.07.141","article-title":"Genetic consultation embedded in a gynecologic oncology clinic improves compliance with guideline-based care","volume":"147","author":"Senter","year":"2017","journal-title":"Gynecol Oncol."},{"key":"2026042814062603300_vmag026-B14","doi-asserted-by":"publisher","first-page":"CD001431","DOI":"10.1002\/14651858.CD001431.pub5","article-title":"Decision aids for people facing health treatment or screening decisions","volume":"4","author":"Stacey","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2026042814062603300_vmag026-B15","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1186\/1472-6947-13-S2-S12","article-title":"Establishing the effectiveness of patient decision aids: key constructs and measurement instruments","volume":"13","author":"Sepucha","year":"2013","journal-title":"BMC Med Inform Decis Mak"},{"key":"2026042814062603300_vmag026-B16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/cge.12430","article-title":"Interactive e-counselling for genetics pre-test decisions: where are we now?: Interactive e-counselling for genetics pre-test decisions","volume":"87","author":"Birch","year":"2015","journal-title":"Clin Genet"},{"key":"2026042814062603300_vmag026-B17","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/pon.1353","article-title":"A randomized trial of a breast\/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling","volume":"17","author":"Wakefield","year":"2008","journal-title":"Psychooncology."},{"key":"2026042814062603300_vmag026-B18","doi-asserted-by":"publisher","author":"Shannon","year":"2023","DOI":"10.1101\/2023.08.11.23293986"},{"key":"2026042814062603300_vmag026-B19","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/s41436-020-0785-6","article-title":"Mainstreaming genetics and genomics: a systematic review of the barriers and facilitators for nurses and physicians in secondary and tertiary care","volume":"22","author":"White","year":"2020","journal-title":"Genet Med."},{"key":"2026042814062603300_vmag026-B20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1186\/s12889-017-4375-8","article-title":"Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: a systematic review","volume":"17","author":"Hann","year":"2017","journal-title":"BMC Public Health"}],"container-title":["Research Connections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rescon\/advance-article-pdf\/doi\/10.1093\/rescon\/vmag026\/67415981\/vmag026.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rescon\/article-pdf\/1\/2\/vmag026\/67415981\/vmag026.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rescon\/article-pdf\/1\/2\/vmag026\/67415981\/vmag026.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:06:38Z","timestamp":1777399598000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rescon\/article\/doi\/10.1093\/rescon\/vmag026\/8529057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4,9]]}},"URL":"https:\/\/doi.org\/10.1093\/rescon\/vmag026","relation":{},"ISSN":["3049-5245"],"issn-type":[{"value":"3049-5245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,4]]},"article-number":"vmag026"}}